Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOSCAR: High-Dose Sandostatin LAR Strategies in Acromegaly
NCT01278342Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Primary completion
- Nov 2009
- Modality
- Peptides
- Countries
- 5
01
Overview
A Phase 4 trial of Octreotide long-acting injection in acromegaly, sponsored by Novartis. Started Sep 2006; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01278342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278342.